Ten-year outcomes of cataract surgery for glaucoma management in patients with primary angle-closure disease.


Journal

Japanese journal of ophthalmology
ISSN: 1613-2246
Titre abrégé: Jpn J Ophthalmol
Pays: Japan
ID NLM: 0044652

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 08 08 2022
accepted: 17 11 2022
pubmed: 24 12 2022
medline: 16 3 2023
entrez: 23 12 2022
Statut: ppublish

Résumé

To investigate the long-term outcomes of cataract surgery for glaucoma management in patients with primary angle-closure disease (PACD). Retrospective case series. We reviewed the medical records of 87 eyes of 87 patients with PACD who underwent uncomplicated cataract surgery alone at the Kobe City Medical Center General Hospital. Only patients with a minimum follow-up of 10 years were included. The patients were divided into PACD spectrum categories: primary angle-closure glaucoma (PACG), primary-angle closure (PAC), and primary angle-closure suspect (PACS). The treatment outcomes were compared among the 3 groups. Intraocular pressure (IOP), number of glaucoma eye drops, requirement of additional glaucoma treatment, visual field progression, and progression to glaucoma during the follow-up period were evaluated. Among the 87 patients, 39 had PACG; 26, PAC; and 22, PACS. Ten years after surgery, the IOP had significantly decreased from baseline in all 3 groups. The rate of requirement of additional glaucoma treatment during the follow-up period was significantly higher in the PACG group than in the other groups. Almost half of the patients with PACG required additional glaucoma treatment; of those patients, six (15.4%) underwent glaucoma surgery. Three patients (11.5%) with PAC required additional glaucoma medication. Visual field progression was observed in 28.1% of the patients with PACG. In 1 patient with PAC, the condition progressed to PACG, but there was no such progression in any of the patients with PACS. We confirmed that cataract surgery had a long-term (> 10 years) effect on IOP reduction in eyes with PACD. Early intervention with cataract surgery may be preferable for glaucoma management in patients with PACD.

Identifiants

pubmed: 36564597
doi: 10.1007/s10384-022-00971-8
pii: 10.1007/s10384-022-00971-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

129-137

Informations de copyright

© 2022. Japanese Ophthalmological Society.

Références

Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081–90.
doi: 10.1016/j.ophtha.2014.05.013 pubmed: 24974815
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–7.
doi: 10.1136/bjo.2005.081224 pubmed: 16488940 pmcid: 1856963
Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86:238–42.
doi: 10.1136/bjo.86.2.238 pubmed: 11815354 pmcid: 1771026
Foster PJ, He M, Liebmann J. Epidemiology, classification and mechanism. In: Weinreb RN, Friedman DS, editors. Angle closure and angle closure glaucoma. Amsterdam: Kugler Publications; 2006. p. 1–20.
Wishart PK, Batterbury M. Ocular hypertension: correlation of anterior chamber angle width and risk of progression to glaucoma. Eye (Lond). 1992;6:24856.
doi: 10.1038/eye.1992.48
Thomas R, George R, Parikh R, Muliyil J, Jacob A. Five year risk of progression of primary angle closure suspects to primary angle closure: a population based study. Br J Ophthalmol. 2003;87:4504.
doi: 10.1136/bjo.87.4.450
Thomas R, Parikh R, Muliyil J, Kumar RS. Five-year risk of progression of primary angle closure to primary angle closure glaucoma: a population-based study. Acta Ophthalmol Scand. 2003;81:480–5.
doi: 10.1034/j.1600-0420.2003.00135.x pubmed: 14510795
Zhang Y, Thomas R, Zhang Q, Li SZ, Wang NL. Progression of primary angle closure suspect to primary angle closure and associated risk factors: the Handan Eye Study. Invest Ophthalmol Vis Sci. 2021;62:2.
doi: 10.1167/iovs.62.7.2 pubmed: 34605879 pmcid: 8496408
He M, Jiang Y, Huang S, Chang DS, Munoz B, Aung T, et al. Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial. Lancet. 2019;393:1609–18.
doi: 10.1016/S0140-6736(18)32607-2 pubmed: 30878226
Teo ZL, Soh ZD, Tham YC, Yu M, Chee ML, Thakur S, et al. Six-year incidence and risk factors for primary angle-closure disease: the Singapore Epidemiology of Eye Diseases Study. Ophthalmology. 2022;129:792–802.
doi: 10.1016/j.ophtha.2022.03.009 pubmed: 35306094
Ang LP, Aung T, Chew PT. Acute primary angle closure in an Asian population: long-term outcome of the fellow eye after prophylactic laser peripheral iridotomy. Ophthalmology. 2000;107:2092–6.
doi: 10.1016/S0161-6420(00)00360-2 pubmed: 11054339
Nonaka A, Kondo T, Kikuchi M, Yamashiro K, Fujihara M, Iwawaki T, et al. Angle widening and alteration of ciliary process configuration after cataract surgery for primary angle closure. Ophthalmology. 2006;113:437–41.
doi: 10.1016/j.ophtha.2005.11.018 pubmed: 16513457
Tarongoy P, Ho CL, Walton DS. Angle-closure glaucoma: the role of the lens in the pathogenesis, prevention, and treatment. Surv Ophthalmol. 2009;54:211–25.
doi: 10.1016/j.survophthal.2008.12.002 pubmed: 19298900
Costa VP, Leung CKS, Kook MS, Lin SC. Global Glaucoma Academy. Clear lens extraction in eyes with primary angle closure and primary angle-closure glaucoma. Surv Ophthalmol. 2020;65:66274.
doi: 10.1016/j.survophthal.2020.04.003
Azuara-Blanco A, Burr J, Ramsay C, Cooper D, Foster PJ, Friedman DS, et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet. 2016;388:1389–97.
doi: 10.1016/S0140-6736(16)30956-4 pubmed: 27707497
Mitchell WG, Azuara-Blanco A, Foster PJ, Halawa O, Burr J, Ramsay CR, et al. Predictors of long-term intraocular pressure control after lens extraction in primary angle closure glaucoma: results from the EAGLE trial. Br J Ophthalmol. 2022. https://doi.org/10.1136/bjophthalmol-2021-319765 . (Published online).
doi: 10.1136/bjophthalmol-2021-319765 pubmed: 35387778
Armstrong RA. Statistical guidelines for the analysis of data obtained from one or both eyes. Ophthalmic Physiol Opt. 2013;33:7–14.
doi: 10.1111/opo.12009 pubmed: 23252852
Harris LS, Galin MA. Prone provocative testing for narrow angle glaucoma. Arch Ophthalmol. 1972;87:493–6.
doi: 10.1001/archopht.1972.01000020495001 pubmed: 5028090
Komori S, Ishida K, Yamamoto T. Results of long-term monitoring of normal-tension glaucoma patients receiving medical therapy: results of an 18-year follow-up. Graefes Arch Clin Exp Ophthalmol. 2014;252:1963–70.
doi: 10.1007/s00417-014-2767-3 pubmed: 25128961
Song MK, Sung KR, Shin JW, Jo YH, Won HJ. Glaucomatous progression after lens extraction in primary angle closure disease spectrum. J Glaucoma. 2020;29:711–7.
doi: 10.1097/IJG.0000000000001537 pubmed: 32366776
Hansapinyo L, Choy BNK, Lai JSM, Tham CCY. Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. J Glaucoma. 2020;29:15–23.
doi: 10.1097/IJG.0000000000001397 pubmed: 31702714
Tham CCY, Kwong YYY, Leung DYL, Lam SW, Li FCH, Chiu TYH, et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology. 2009;116(725–31):731.e1-3.
Tham CCY, Kwong YYY, Leung DYL, Lam SW, Li FCH, Chiu TYH, et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology. 2008;115:2167-73.e2.
doi: 10.1016/j.ophtha.2008.06.016 pubmed: 18801576
Peng PH, Nguyen H, Lin HS, Nguyen N, Lin S. Long-term outcomes of laser iridotomy in Vietnamese patients with primary angle closure. Br J Ophthalmol. 2011;95:1207–11.
doi: 10.1136/bjo.2010.181016 pubmed: 21169268
Hyams SW, Keroub C, Pokotilo E. Mixed glaucoma. Br J Ophthalmol. 1977;61:105–6.
doi: 10.1136/bjo.61.2.105 pubmed: 843504 pmcid: 1042891
Nouri-Mahdavi K, Brigatti L, Weitzman M, Caprioli J. Outcomes of trabeculectomy for primary open-angle glaucoma. Ophthalmology. 1995;102:1760–9.
doi: 10.1016/S0161-6420(95)30796-8 pubmed: 9098275
Kotecha A, Spratt A, Bunce C, Garway-Heath DF, Khaw PT, Viswanathan A, et al. Optic disc and visual field changes after trabeculectomy. Invest Ophthalmol Vis Sci. 2009;50:4693–9.
doi: 10.1167/iovs.08-3115 pubmed: 19474409
Downs JC, Girkin CA. Lamina cribrosa in glaucoma. Curr Opin Ophthalmol. 2017;28:113–9.
doi: 10.1097/ICU.0000000000000354 pubmed: 27898470 pmcid: 5480216
Park HYL, Shin HY, Jung KI, Park CK. Changes in the lamina and prelamina after intraocular pressure reduction in patients with primary open-angle glaucoma and acute primary angle-closure. Invest Ophthalmol Vis Sci. 2014;55:233.
doi: 10.1167/iovs.12-10329 pubmed: 24204049
Hamanaka T, Kasahara K, Takemura T. Histopathology of the trabecular meshwork and Schlemm’s canal in primary angle-closure glaucoma. Invest Ophthalmol Vis Sci. 2011;52:8849–61.
doi: 10.1167/iovs.11-7591 pubmed: 21960557

Auteurs

Daiki Sakai (D)

Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan. dsakai1027@gmail.com.
Department of Ophthalmology, Kobe City Medical Center General Hospital, Kobe, Japan. dsakai1027@gmail.com.
Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan. dsakai1027@gmail.com.

Shogo Yamamoto (S)

Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
Department of Ophthalmology, Kobe City Medical Center General Hospital, Kobe, Japan.

Satoru Yoshimizu (S)

Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
Department of Ophthalmology, Kobe City Medical Center General Hospital, Kobe, Japan.

Fumitaka Hirose (F)

Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
Shin-Kobe Hirose Eye Clinic, Kobe, Japan.

Masashi Fujihara (M)

Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
Department of Ophthalmology, Kobe City Medical Center General Hospital, Kobe, Japan.

Makoto Nakamura (M)

Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan.

Yasuo Kurimoto (Y)

Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
Department of Ophthalmology, Kobe City Medical Center General Hospital, Kobe, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH